demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID-19 mild to moderate
COVID-19 mild to moderate
favipiravir FACCT Trial Udwadia AVIFAVIR Shenoy S NCT04542694 Dabbous HM Ruzhentsova T Holubar M Solaymani-Dodaran IRCT20151227025726N14 // U07 Shinkai

1 studies excluded by filtering options 2

6526 Dabbous, 2021 213excludedhigh risk of bias